Director/PDMR Shareholding

RNS Number : 8612W
GlaxoSmithKline PLC
14 February 2017
 

GlaxoSmithKline plc (the 'Company')

 

Transaction notification

 

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Sir Andrew Witty

b)

Position/status

Chief Executive Officer

c)

Initial notification/

amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial  instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

 

ISIN: GB0009252882

 

b)

Nature of the transaction

Disposal of 63,441 Ordinary Shares on 10 February 2017 at nil consideration, by way of a gift to the University of Nottingham to help develop student skills and employability. The closing price of an Ordinary Share on 10 February 2017 was £15.91.

 

c)

Price(s) and

volume(s)

Price(s)

Volume(s)

£0.00

63,441

  

d)

Aggregated information

 

Aggregated volume Price

n/a (single transaction)

 

 

 

 

 

e)

Date of the transaction

2017-02-10

f)

Place of the transaction

 

n/a

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHLZLFFDLFZBBF

Companies

GSK (GSK)
UK 100

Latest directors dealings